1. Home
  2. IOSP vs ZLAB Comparison

IOSP vs ZLAB Comparison

Compare IOSP & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IOSP
  • ZLAB
  • Stock Information
  • Founded
  • IOSP 1938
  • ZLAB 2013
  • Country
  • IOSP United States
  • ZLAB China
  • Employees
  • IOSP N/A
  • ZLAB N/A
  • Industry
  • IOSP Major Chemicals
  • ZLAB Biotechnology: Pharmaceutical Preparations
  • Sector
  • IOSP Industrials
  • ZLAB Health Care
  • Exchange
  • IOSP Nasdaq
  • ZLAB Nasdaq
  • Market Cap
  • IOSP 2.6B
  • ZLAB 3.0B
  • IPO Year
  • IOSP 1998
  • ZLAB 2017
  • Fundamental
  • Price
  • IOSP $114.47
  • ZLAB $26.05
  • Analyst Decision
  • IOSP
  • ZLAB Strong Buy
  • Analyst Count
  • IOSP 0
  • ZLAB 3
  • Target Price
  • IOSP N/A
  • ZLAB $55.00
  • AVG Volume (30 Days)
  • IOSP 145.4K
  • ZLAB 482.4K
  • Earning Date
  • IOSP 02-18-2025
  • ZLAB 02-25-2025
  • Dividend Yield
  • IOSP 1.35%
  • ZLAB N/A
  • EPS Growth
  • IOSP 13.00
  • ZLAB N/A
  • EPS
  • IOSP 5.73
  • ZLAB N/A
  • Revenue
  • IOSP $1,873,300,000.00
  • ZLAB $355,748,000.00
  • Revenue This Year
  • IOSP N/A
  • ZLAB $49.04
  • Revenue Next Year
  • IOSP $4.08
  • ZLAB $46.70
  • P/E Ratio
  • IOSP $19.98
  • ZLAB N/A
  • Revenue Growth
  • IOSP N/A
  • ZLAB 35.01
  • 52 Week Low
  • IOSP $103.65
  • ZLAB $13.48
  • 52 Week High
  • IOSP $133.71
  • ZLAB $36.60
  • Technical
  • Relative Strength Index (RSI)
  • IOSP 58.69
  • ZLAB 50.14
  • Support Level
  • IOSP $111.94
  • ZLAB $23.82
  • Resistance Level
  • IOSP $114.47
  • ZLAB $25.64
  • Average True Range (ATR)
  • IOSP 2.53
  • ZLAB 1.24
  • MACD
  • IOSP 0.90
  • ZLAB 0.06
  • Stochastic Oscillator
  • IOSP 98.45
  • ZLAB 64.45

About IOSP Innospec Inc.

Innospec Inc manufactures and sells a variety of chemicals and fuel additives. The firm organizes itself into three segments based on product type. The fuel specialties segment, which generates the majority of revenue, sells products used to improve fuel efficiency, boost engine performance, and reduce emissions for automobiles, boats, and airplanes. It also sells products used by oil field services providers in the extraction of oil and gas. The performance chemicals segment sells products to the personal-care industry. The Oilfield Services segment develops and markets products to prevent loss of mud.

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-2306 for treatments across multiple solid tumor types including ovarian and certain types of breast and lung cancers; ZL-2401 which is an antibiotic in a new class of tetracycline derivatives; and ZL-2301 is an oral, small molecule which targets HCC.

Share on Social Networks: